Ibex Medical Analytics, a leader in AI-powered cancer diagnostics, has launched a new cancer detection platform.  The Galen 3.0 uses improved AI algorithms to detect cancer in prostate, breast and gastric biopsies. The platform also calculates a Gleason score (the grading system used to determine the aggressiveness of prostate cancer), tumor size, and percentage for […]

Patients provide a single breath sample by post for early diagnosis

An Israeli startup transforming drug development and clinical treatment partners with the US-based contract research organization Sirona DX

Patient, 60, is given alpha-radiation to target the tumor without harming healthy tissue in ‘historical’ procedure

Israeli personalized cancer therapy company OncoHost, announced on Tuesday that it raised $35 million in a Series C funding round to finance its multicenter PROPHETIC trial that tests the company’s machine-learning-based host response profiling platform PROphet, a precision oncology diagnostic solution.  The funding will also be used to support the company’s commercial launch, which is […]

The research was conducted by a global team of scientists in the laboratory of Prof. Moshe Elkabets at the Ben-Gurion University of the Negev.

Former Technion professor Yoram Palti recognized for the prize for developing a groundbreaking cancer treatment

To mark World Cancer Day, we've highlighted some innovative strategies for cancer therapy developed in Israel.

ImmPACT Bio was formed from a merger with Israeli company Immpact, which was raised in the FutuRX biotech incubator, and US company Kalthera.

Tumors in mice lost half their size when injected with eosinophils, best known for inducing allergies; promising results also seen in human tumor cells in vitro.

OncoHost's platform combines proteomic analysis with AI to predict host responses to immunotherapy, and gain insight into cancer treatments.

Kahr said the funding will be used to advance clinical development for DSP107, the fusion protein meant to treat blood and bone cancers.

Ibex Medical Analytics' AI-powered technology helps pathologists detect and grade cancer in biopsies.

Founded in 2017, Nucleai developed a platform that leverages tissue datasets to produce insights into cancer biology, increase clinical trial efficacy and improve patient care.

Interreg Germany-Denmark’s Changing Cancer Care initiative launches study to assess PixCell Medical’s HemoScreen hematology analyzer for home-based blood testing.